Instil Bio Stock Target Price
| TIL Stock | USD 19.23 1.52 7.33% |
Fundamental analysis of Instil Bio allows traders to better anticipate movements in Instil Bio's stock price by examining its financial health and performance throughout various phases of its business cycle.
Instil | Target Price | Build AI portfolio with Instil Stock |
Instil Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Instil Bio's direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Instil Bio could also be used in its relative valuation, which is a method of valuing Instil Bio by comparing valuation metrics of similar companies.Instil Bio is currently under evaluation in target price category among its peers.
Instil Bio ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Instil Bio's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Instil Bio's managers, analysts, and investors.Environmental | Governance | Social |
Instil Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.13 | ||||
| Current Valuation | 111.53 M | ||||
| Shares Outstanding | 6.75 M | ||||
| Shares Owned By Insiders | 6.32 % | ||||
| Shares Owned By Institutions | 68.77 % | ||||
| Number Of Shares Shorted | 950.83 K | ||||
| Price To Earning | 18.31 X | ||||
| Price To Book | 0.90 X | ||||
| Price To Sales | 55,330 X | ||||
| Gross Profit | 138 K | ||||
| EBITDA | (61.53 M) | ||||
| Net Income | (74.14 M) | ||||
| Cash And Equivalents | 354.61 M | ||||
| Cash Per Share | 2.73 X | ||||
| Total Debt | 86.89 M | ||||
| Debt To Equity | 0.12 % | ||||
| Current Ratio | 8.51 X | ||||
| Book Value Per Share | 19.50 X | ||||
| Cash Flow From Operations | (55.7 M) | ||||
| Short Ratio | 6.64 X | ||||
| Earnings Per Share | (13.05) X | ||||
| Target Price | 95.75 | ||||
| Number Of Employees | 14 | ||||
| Beta | 2.08 | ||||
| Market Capitalization | 140.08 M | ||||
| Total Asset | 263.57 M | ||||
| Retained Earnings | (655.12 M) | ||||
| Working Capital | 116.57 M | ||||
| Net Asset | 263.57 M |
About Instil Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Instil Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Instil Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Instil Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Instil Bio Piotroski F Score and Instil Bio Altman Z Score analysis. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.